The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Sacrosidase (Brand name: Sucraid®)
- Manufactured by
QOL Medical, LLC
FDA-approved indication: Oral replacement therapy of the genetically determined sucrase deficiency, which is part of congenital sucrease-isomaltase deficiency.
National Library of Medicine Drug Information Portal